Theravance Biopharma Inc.

NAS: TBPH

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204752752/composite

$

17.96

Change

0.00 0.00%

Volume

Volume 8,462

Aug 7, 2020, 7:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204752752/composite

Previous close

$ 20.84

$ 17.96

Change

-2.88 -13.82%

Day low

Day high

$17.69

$20.38

Open
Open: 19.11

52 week low

52 week high

$15.72

$31.54

Open

Market cap

$1.13B

Average volume

517,620

P/E ratio

N/A

Rev. per Employee

$166,309

EPS

-4.61

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/tbph

MarketWatch News on TBPH

  1. Theravance Biopharma initiated at overweight with $29 price target at JPMorgan

    8:29 a.m. July 7, 2020

    - Tonya Garcia

  2. Theravance Biopharma downgraded to underperform from neutral at RW Baird

    7:02 a.m. Oct. 12, 2016

    - Tomi Kilgore

  3. Theravance Biopharma downgraded to underperform from neutral at BofA Merrill Lynch

    11:44 a.m. Aug. 3, 2016

    - Tomi Kilgore

  4. Theravance Biopharma started at outperform with $26 stock price target at Leerink Partners

    7:28 a.m. May 12, 2016

    - Tomi Kilgore

  5. Eight Undervalued Key Antibiotics Players

    9:04 a.m. Feb. 26, 2015

    - Barron's Online

  6. At Theravance, It's Hard to Breathe Easy

    3:07 a.m. July 26, 2014

    - Barron's Online

  7. At Theravance, It's Hard to Breathe Easy

    4:04 a.m. July 26, 2014

    - Barron's Online

Analyst Ratings

/news/nonmarketwatch/company/us/tbph

Other News on TBPH

  1. USANA (USNA) to Report Q2 Earnings: What's in the Cards?

    3:16 p.m. July 17, 2020

    - Zacks.com

  2. 10-Q: THERAVANCE BIOPHARMA, INC.

    5:06 p.m. May 8, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  3. Loading more headlines...

Earnings Announcement

/news/pressrelease/company/us/tbph

Press Releases on TBPH

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.